Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma.

Meiting ChenZhao WangXiaojie FangYuyi YaoQuanguang RenZegeng ChenYing TianFei PanXiaoqian LiZhiming LiQingqing CaiHe Huang Tongyu Lin

Published in: Cancer biology & medicine (2022)

The modified R-CODOX-M/IVAC chemotherapy regimen was effective for sporadic Burkitt lymphoma in the Chinese population, with a lower toxicity than standard regimens.

Keyphrases

diffuse large b cell lymphoma
late onset
locally advanced
amyotrophic lateral sclerosis
oxidative stress
squamous cell carcinoma
early onset